Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.

1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer...

Full description

Bibliographic Details
Main Authors: Borna A Nyaoke, Gaudensia N Mutua, Rose Sajabi, Delvin Nyasani, Marianne W Mureithi, Omu A Anzala
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5589082?pdf=render
_version_ 1818244929529315328
author Borna A Nyaoke
Gaudensia N Mutua
Rose Sajabi
Delvin Nyasani
Marianne W Mureithi
Omu A Anzala
author_facet Borna A Nyaoke
Gaudensia N Mutua
Rose Sajabi
Delvin Nyasani
Marianne W Mureithi
Omu A Anzala
author_sort Borna A Nyaoke
collection DOAJ
description 1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer motivators for enrolment, retention and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase enrolment of volunteers in future HIV vaccine clinical trials. The health belief model classifies motivators into social benefits such as 'advancing research' and collaboration with science, and personal benefits such as health benefits and financial interests.A thematic analysis was carried out on data obtained from four HIV clinical trials conducted at KAVI-Institute of Clinical Research in Nairobi Kenya from 2009 to 2015. Responses were obtained from a Questionnaire administered to the volunteers during their screening visit at the research site.Of the 281 healthy, HIV-uninfected volunteers participating in this study; 38% were motivated by personal benefits including, 31% motivated by health benefits and 7% motivated by possible financial gains. In addition, 62% of the volunteers were motivated by social benefits with 20% of who were seeking to help their family/society/world while 42% were interested in advancing research.The majority of volunteers in the HIV vaccine trials at our site were motivated by social benefits, suggesting that altruism can be a major contributor to participation in HIV vaccine studies. Personal benefits were a secondary motivator for the volunteers. The motivators to volunteer in HIV clinical trials were similar across ages, education level and gender. Education on what is needed (including volunteer participation) to develop an efficacious vaccine could be the key to greater volunteer motivation to participate in HIV vaccine clinical trials.
first_indexed 2024-12-12T14:24:50Z
format Article
id doaj.art-09d2eb19dde645179929b17782e2138f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T14:24:50Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-09d2eb19dde645179929b17782e2138f2022-12-22T00:21:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018378810.1371/journal.pone.0183788Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.Borna A NyaokeGaudensia N MutuaRose SajabiDelvin NyasaniMarianne W MureithiOmu A Anzala1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer motivators for enrolment, retention and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase enrolment of volunteers in future HIV vaccine clinical trials. The health belief model classifies motivators into social benefits such as 'advancing research' and collaboration with science, and personal benefits such as health benefits and financial interests.A thematic analysis was carried out on data obtained from four HIV clinical trials conducted at KAVI-Institute of Clinical Research in Nairobi Kenya from 2009 to 2015. Responses were obtained from a Questionnaire administered to the volunteers during their screening visit at the research site.Of the 281 healthy, HIV-uninfected volunteers participating in this study; 38% were motivated by personal benefits including, 31% motivated by health benefits and 7% motivated by possible financial gains. In addition, 62% of the volunteers were motivated by social benefits with 20% of who were seeking to help their family/society/world while 42% were interested in advancing research.The majority of volunteers in the HIV vaccine trials at our site were motivated by social benefits, suggesting that altruism can be a major contributor to participation in HIV vaccine studies. Personal benefits were a secondary motivator for the volunteers. The motivators to volunteer in HIV clinical trials were similar across ages, education level and gender. Education on what is needed (including volunteer participation) to develop an efficacious vaccine could be the key to greater volunteer motivation to participate in HIV vaccine clinical trials.http://europepmc.org/articles/PMC5589082?pdf=render
spellingShingle Borna A Nyaoke
Gaudensia N Mutua
Rose Sajabi
Delvin Nyasani
Marianne W Mureithi
Omu A Anzala
Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
PLoS ONE
title Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
title_full Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
title_fullStr Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
title_full_unstemmed Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
title_short Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
title_sort volunteer motivators for participating in hiv vaccine clinical trials in nairobi kenya
url http://europepmc.org/articles/PMC5589082?pdf=render
work_keys_str_mv AT bornaanyaoke volunteermotivatorsforparticipatinginhivvaccineclinicaltrialsinnairobikenya
AT gaudensianmutua volunteermotivatorsforparticipatinginhivvaccineclinicaltrialsinnairobikenya
AT rosesajabi volunteermotivatorsforparticipatinginhivvaccineclinicaltrialsinnairobikenya
AT delvinnyasani volunteermotivatorsforparticipatinginhivvaccineclinicaltrialsinnairobikenya
AT mariannewmureithi volunteermotivatorsforparticipatinginhivvaccineclinicaltrialsinnairobikenya
AT omuaanzala volunteermotivatorsforparticipatinginhivvaccineclinicaltrialsinnairobikenya